Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Schorge

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Human Pathology|February 24, 1999
Understanding the pathogenesis of primary peritoneal carcinoma: involvement of the BRCA1 and p53 genesJ O Schorge, S C Mok
Gynecologic Oncology|August 6, 2000
Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary reportJ O Schorge, K R Lee, E E Sheets
Southern Medical Journal|July 1, 1991
Epidemiologic characteristics of drug use during pregnancy: experience in a Nashville hospitalP S Cartwright, J O Schorge, F J McLaughlin
Gynecologic Oncology|April 29, 2000
The definition of stage IA(1) cervical adenocarcinoma and selection criteria for nonradical surgical managementJ O Schorge, K R Lee, E E Sheets
The Journal of Reproductive Medicine|August 7, 1998
Postpartum and vulvar necrotizing fasciitis. Early clinical diagnosis and histopathologic correlationJ O Schorge, S R Granter, L H Lerner, et al.
Gynecologic Oncology|September 28, 2000
Conservative management of adenocarcinoma in situ of the cervixC H Shin, J O Schorge, K R Lee, et al.
The Journal of Reproductive Medicine|October 12, 2000
Recent advances in gestational trophoblastic diseaseJ O Schorge, D P Goldstein, M R Bernstein, et al.
Current Treatment Options in Oncology|June 12, 2002
Gestational trophoblastic diseaseJ O Schorge, D P Goldstein, M R Bernstein, et al.
The Journal of Reproductive Medicine|September 14, 1999
Clinically significant venous thromboembolism after gynecologic surgeryJ O Schorge, S Z Goldhaber, L R Duska, et al.
Gynecologic Oncology|October 1, 1996
The effect of postsurgical therapy on stage III endometrial carcinomaJ O Schorge, K L Molpus, A Goodman, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Human Pathology|February 24, 1999
Understanding the pathogenesis of primary peritoneal carcinoma: involvement of the BRCA1 and p53 genesJ O Schorge, S C Mok
Gynecologic Oncology|August 6, 2000
Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary reportJ O Schorge, K R Lee, E E Sheets
Southern Medical Journal|July 1, 1991
Epidemiologic characteristics of drug use during pregnancy: experience in a Nashville hospitalP S Cartwright, J O Schorge, F J McLaughlin
Gynecologic Oncology|April 29, 2000
The definition of stage IA(1) cervical adenocarcinoma and selection criteria for nonradical surgical managementJ O Schorge, K R Lee, E E Sheets
The Journal of Reproductive Medicine|August 7, 1998
Postpartum and vulvar necrotizing fasciitis. Early clinical diagnosis and histopathologic correlationJ O Schorge, S R Granter, L H Lerner, et al.
Gynecologic Oncology|September 28, 2000
Conservative management of adenocarcinoma in situ of the cervixC H Shin, J O Schorge, K R Lee, et al.
The Journal of Reproductive Medicine|October 12, 2000
Recent advances in gestational trophoblastic diseaseJ O Schorge, D P Goldstein, M R Bernstein, et al.
Current Treatment Options in Oncology|June 12, 2002
Gestational trophoblastic diseaseJ O Schorge, D P Goldstein, M R Bernstein, et al.
The Journal of Reproductive Medicine|September 14, 1999
Clinically significant venous thromboembolism after gynecologic surgeryJ O Schorge, S Z Goldhaber, L R Duska, et al.
Gynecologic Oncology|October 1, 1996
The effect of postsurgical therapy on stage III endometrial carcinomaJ O Schorge, K L Molpus, A Goodman, et al.
Pageof 3